Regulations.gov document
Requests for Reconsideration at the Division Level Under the Generic Drug User Fee…
Notice · FDA-2017-D-5868 · posted Jan 11, 2024
Key facts
| Document ID | FDA-2017-D-5868-0004 |
|---|---|
| Title | Requests for Reconsideration at the Division Level Under the Generic Drug User Fee Amendments; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2017-D-5868 |
| Posted | Jan 11, 2024 |
| Federal Register citation | 89 FR 1923 |
| FR document number | 2024-00403 |
| Comment period opens | Jan 11, 2024 |
| Effective date | Jan 11, 2024 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: